Interleukin-1β induces macrophage inflammatory protein-1β expression in human hepatocytes

Hanada, 2002, Regulation of cytokine signaling and inflammation, Cytokine Growth Factor Rev., 13, 413, 10.1016/S1359-6101(02)00026-6 Hamann, 2000, Activation induces rapid and profound alterations in the trafficking of T cells, Eur. J. Immunol., 30, 3207, 10.1002/1521-4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2-L Granowitz, 1991, Production of interleukin-1-receptor antagonist during experimental endotoxaemia, Lancet, 338, 1423, 10.1016/0140-6736(91)92725-H Onozaki, 1985, Human interleukin 1 is a cytocidal factor for several tumor cell lines, J. Immunol., 135, 3962, 10.4049/jimmunol.135.6.3962 Peters, 1996, Actions of cytokines on the immune response and viral interactions: an overview, Hepatology, 23, 909, 10.1002/hep.510230436 Lu, 2003, Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas, Am. J. Pathol., 162, 1249, 10.1016/S0002-9440(10)63921-1 Kato, 2002, Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion, Am. J. Pathol., 161, 1797, 10.1016/S0002-9440(10)64456-2 Zlotnik, 2000, Chemokines: a new classification system and their role in immunity, Immunity, 12, 121, 10.1016/S1074-7613(00)80165-X Shindo, 1996, Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB), Clin. Exp. Immunol., 105, 254, 10.1046/j.1365-2249.1996.d01-759.x Llorent, 1996, Cytokine gene expression in cirrhotic and non-cirrhotic human liver, J. Hepatol., 24, 555, 10.1016/S0168-8278(96)80140-1 Mazzella, 1999, Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial, Am. J. Gastroenterol., 94, 2246, 10.1111/j.1572-0241.1999.01300.x von Schweinitz, 1993, Production of interleukin-1 beta and interleukin-6 in hepatoblastoma, Int. J. Cancer, 53, 728, 10.1002/ijc.2910530504 Diehl, 1999, Cytokines and the molecular mechanisms of alcoholic liver disease, Alcohol. Clin. Exp. Res., 23, 1419, 10.1111/j.1530-0277.1999.tb04662.x McClain, 1999, Cytokines in alcoholic liver disease, Semin. Liver Dis., 19, 205, 10.1055/s-2007-1007110 McClain, 1993, Cytokines and alcoholic liver disease, Semin. Liver Dis., 13, 170, 10.1055/s-2007-1007347 Tilg, 1992, Serum levels of cytokines in chronic liver diseases, Gastroenterology, 103, 264, 10.1016/0016-5085(92)91122-K Baggiolini, 1998, Chemokines and leukocyte traffic, Nature, 392, 565, 10.1038/33340 Rollins, 1997, Chemokines, Blood, 90, 909, 10.1182/blood.V90.3.909 Shields, 1999, Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver, J. Immunol., 163, 6236, 10.4049/jimmunol.163.11.6236 Afford, 1998, Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis, J. Pathol., 186, 82, 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D Adams, 1997, Chemokines: leucocyte recruitment and activation cytokines, Lancet, 349, 490, 10.1016/S0140-6736(96)07524-1 Adams, 1996, Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation, Transplantation, 61, 817, 10.1097/00007890-199603150-00024 Hassan, 1986, Purification of human monocytes on gelatin-coated surfaces, J. Immunol. Methods, 95, 273, 10.1016/0022-1759(86)90415-1 Petrak, 1994, Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription, J. Immunol., 153, 2046, 10.4049/jimmunol.153.5.2046 Powell, 1993, Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primates, Clin. Exp. Immunol., 91, 473, 10.1111/j.1365-2249.1993.tb05927.x Ghosh, 2002, Missing pieces in the NF-kappaB puzzle, Cell, 109, S81, 10.1016/S0092-8674(02)00703-1 Roebuck, 1999, Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB, J. Leukoc. Biol., 65, 291, 10.1002/jlb.65.3.291 Richmond, 2002, Nf-kappa B, chemokine gene transcription and tumor growth, Nat. Rev. Immunol., 2, 664, 10.1038/nri887 Natarajan, 1996, Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B, Proc. Natl. Acad. Sci. USA, 93, 9090, 10.1073/pnas.93.17.9090 Schall, 1994, Chemokines, leukocyte trafficking, and inflammation, Curr. Opin. Immunol., 6, 865, 10.1016/0952-7915(94)90006-X Butcher, 1996, Lymphocyte homing and homeostasis, Science, 272, 60, 10.1126/science.272.5258.60 Springer, 1994, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm, Cell, 76, 301, 10.1016/0092-8674(94)90337-9 Tanaka, 1993, Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes, Immunol. Today, 14, 111, 10.1016/0167-5699(93)90209-4 Apolinario, 2002, Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease, Am. J. Gastroenterol., 97, 2861, 10.1111/j.1572-0241.2002.07054.x Goddard, 2001, Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants, Transplantation, 72, 1957, 10.1097/00007890-200112270-00016 Yoong, 1999, Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma, Hepatology, 30, 100, 10.1002/hep.510300147 Muto, 1988, Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure, Lancet, 2, 72, 10.1016/S0140-6736(88)90006-2 Khoruts, 1991, Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients, Hepatology, 13, 267, 10.1002/hep.1840130211 Tilg, 1993, Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease, Hepatology, 18, 1132, 10.1002/hep.1840180519 McClain, 1986, Serum interleukin-1 (IL-1) activity in alcoholic hepatitis, Life Sci., 39, 1479, 10.1016/0024-3205(86)90554-0 Kishihara, 1996, IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C, Dig. Dis. Sci., 41, 315, 10.1007/BF02093821 Andus, 1991, Effects of cytokines on the liver, Hepatology, 13, 364, 10.1002/hep.1840130226 Napoli, 1994, Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis, Gastroenterology, 107, 789, 10.1016/0016-5085(94)90128-7 Dinarello, 1996, Biologic basis for interleukin-1 in disease, Blood, 87, 2095, 10.1182/blood.V87.6.2095.bloodjournal8762095 El-Omar, 2001, The importance of interleukin 1beta in Helicobacter pylori associated disease, Gut, 48, 743, 10.1136/gut.48.6.743 Zhu, 2003, Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway, J. Virol., 77, 5493, 10.1128/JVI.77.9.5493-5498.2003 Guo, 2003, Interleukin-1beta stimulates macrophage inflammatory protein-1alpha and 1-beta expression in human neuronal cells (NT2-N), J. Neurochem., 84, 997, 10.1046/j.1471-4159.2003.01609.x Fujimori, 2003, Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptomeningeal cells, J. Biol. Chem., 278, 6018, 10.1074/jbc.M208288200 Parnet, 2003, NF kappa B activation in mouse pituitary: comparison of response to interleukin-1 beta and lipopolysaccharide, J. Neuroendocrinol., 15, 304, 10.1046/j.1365-2826.2003.01013.x Jiang, 2002, Growth factors enhance interleukin-1 beta-induced persistent activation of nuclear factor-kappa B in rat vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol., 22, 1811, 10.1161/01.ATV.0000037679.60584.3F Parikh, 1997, IL-6 production in human intestinal epithelial cells following stimulation with IL-1 beta is associated with activation of the transcription factor NF-kappa B, J. Surg. Res., 69, 139, 10.1006/jsre.1997.5061 Kim, 2001, Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms, FASEB J., 15, 2551, 10.1096/fj.01-0217